Mizuho Medy Co.,Ltd. (4595.T)
JPY 1503.0
(-0.27%)
JPY 1503.0
(-0.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.02 Billion JPY | -43.08% |
| 2022 | 14.1 Billion JPY | 46.08% |
| 2021 | 9.65 Billion JPY | 249.87% |
| 2020 | 2.75 Billion JPY | -36.42% |
| 2019 | 4.33 Billion JPY | 0.3% |
| 2018 | 4.32 Billion JPY | 18.24% |
| 2017 | 3.65 Billion JPY | 14.69% |
| 2016 | 3.19 Billion JPY | 19.92% |
| 2015 | 2.66 Billion JPY | 0.43% |
| 2014 | 2.64 Billion JPY | 25.97% |
| 2013 | 2.1 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.32 Billion JPY | -32.41% |
| 2024 Q1 | 1.95 Billion JPY | -9.85% |
| 2023 Q4 | 2.16 Billion JPY | -18.16% |
| 2023 Q2 | 1.54 Billion JPY | -9.19% |
| 2023 Q3 | 2.65 Billion JPY | 71.24% |
| 2023 FY | 8.02 Billion JPY | -43.08% |
| 2023 Q1 | 1.7 Billion JPY | -47.73% |
| 2022 Q2 | 2.55 Billion JPY | -24.11% |
| 2022 Q3 | 4.9 Billion JPY | 91.83% |
| 2022 Q4 | 3.26 Billion JPY | -33.55% |
| 2022 FY | 14.1 Billion JPY | 46.08% |
| 2022 Q1 | 3.37 Billion JPY | 83.9% |
| 2021 Q4 | 1.83 Billion JPY | -44.9% |
| 2021 Q3 | 3.32 Billion JPY | 11.5% |
| 2021 Q2 | 2.98 Billion JPY | 97.97% |
| 2021 FY | 9.65 Billion JPY | 249.87% |
| 2021 Q1 | 1.5 Billion JPY | 18.76% |
| 2020 Q4 | 1.26 Billion JPY | 172.33% |
| 2020 Q3 | 466.07 Million JPY | 38.4% |
| 2020 Q2 | 336.74 Million JPY | -50.96% |
| 2020 Q1 | 686.71 Million JPY | -55.53% |
| 2020 FY | 2.75 Billion JPY | -36.42% |
| 2019 Q2 | 668.35 Million JPY | -45.77% |
| 2019 FY | 4.33 Billion JPY | 0.3% |
| 2019 Q4 | 1.54 Billion JPY | 72.63% |
| 2019 Q3 | 894.44 Million JPY | 33.83% |
| 2019 Q1 | 1.23 Billion JPY | -15.87% |
| 2018 FY | 4.32 Billion JPY | 18.24% |
| 2018 Q3 | 731.32 Million JPY | 17.35% |
| 2018 Q1 | 1.5 Billion JPY | 7.61% |
| 2018 Q2 | 623.17 Million JPY | -58.65% |
| 2018 Q4 | 1.46 Billion JPY | 100.31% |
| 2017 Q3 | 593.04 Million JPY | -0.04% |
| 2017 FY | 3.65 Billion JPY | 14.69% |
| 2017 Q1 | 1.07 Billion JPY | -17.12% |
| 2017 Q4 | 1.4 Billion JPY | 136.15% |
| 2017 Q2 | 593.29 Million JPY | -44.67% |
| 2016 Q3 | 433.69 Million JPY | -9.97% |
| 2016 Q4 | 1.29 Billion JPY | 198.31% |
| 2016 Q1 | 981.4 Million JPY | 3.59% |
| 2016 FY | 3.19 Billion JPY | 19.92% |
| 2016 Q2 | 481.7 Million JPY | -50.92% |
| 2015 FY | 2.66 Billion JPY | 0.43% |
| 2015 Q4 | 947.35 Million JPY | 0.0% |
| 2014 FY | 2.64 Billion JPY | 25.97% |
| 2013 FY | 2.1 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 83.538% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 99.633% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 95.731% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 97.826% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -126.661% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 91.728% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 79.002% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 98.631% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -33.807% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 89.837% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 84.587% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | 40.625% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -3.718% |
| Tsumura & Co. | 68.81 Billion JPY | 88.338% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | 78.507% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | 67.628% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 90.138% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | 51.403% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 84.007% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 84.386% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -643.811% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | 18.43% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -81.947% |
| MedRx Co., Ltd | 26 Million JPY | -30768.142% |
| Solasia Pharma K.K. | 337 Million JPY | -2281.518% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 1098009.302% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | 73.828% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 85.225% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -21163.557% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 92.897% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -20.876% |